comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 11:45:36 - browse：6977

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Hormonal contraceptives don’t actually treat endometriosis

WSS

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

'Make People Better': The CRISPR babies story you probably don't know

Crinetics acromegaly drug succeeds in late

Why Novartis is changing the name of its research labs

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

knowledge

comprehensive

leisure time

What does generative AI mean for health care? We asked experts

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

BioMarin wins approval for gene therapy to treat hemophilia A

Judge denies Trump's request for new trial in E. Jean Carroll case

The high cost of giving birth even with insurance

Dementia risk linked to living in disadvantaged areas: Study

The high cost of giving birth even with insurance

US jobless claims fall again as labor market continues to flash strength

As demand for Covid shots wanes, Moderna seeks its next success

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

leisure time

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

When a patient nears the end, a feared therapy can comfort

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

A new ‘biological computer' targets cancer while sparing healthy cells

Mystery swirls around US soldier who entered North Korea days ago, officials say

explore

focus

leisure time

explore